(S1 (S (S (NP (NP (NN Bruton) (POS 's)) (NN tyrosine) (NN kinase)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN IkappaB) (NN kinase)) (CC and) (NP (JJ nuclear) (NN factor) (NN kappaB)))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN B) (NN cell) (NN receptor) (NN engagement)))))))))) (. .)))
(S1 (S (S (NP (NP (NNS Mutations)) (PP (IN in) (NP (NP (DT the) (NN gene)) (VP (VBG encoding) (NP (NP (NN Bruton) (POS 's) (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN btk)) (-RRB- -RRB-))))))) (VP (VBP cause) (NP (NP (DT the) (NN B) (NN cell) (NN deficiency) (NNS diseases)) (NP (NP (NP (JJ X-linked) (NN agammaglobulinemia)) (PRN (-LRB- -LRB-) (NP (NN XLA)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS humans)) (CC and) (NP (NP (JJ X-linked) (NN immunodeficiency)) (PRN (-LRB- -LRB-) (NP (NN xid)) (-RRB- -RRB-))))) (PP (IN in) (NP (NNS mice))))))) (. .)))
(S1 (S (S (NP (ADJP (ADJP (FW In) (FW vivo)) (CC and) (ADJP (FW in) (FW vitro))) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (DT the) (NN BTK) (NN protein)) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (NP (NN B) (NN cell) (NN survival)) (, ,) (NP (NN cell) (NN cycle) (NN progression)) (, ,) (CC and) (NP (NN proliferation))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NP (NN B) (NN cell) (NN antigen) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN BCR)) (-RRB- -RRB-))) (NN stimulation))))))))))))) (. .)))
(S1 (S (S (NP (NN BCR) (NN stimulation)) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NN transcription) (NN factor) (JJ nuclear) (NN factor) (-LRB- -LRB-) (NN NF) (-RRB- -RRB-) (NN -kappaB)) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN turn))) (VP (VBZ regulates) (NP (NP (NNS genes)) (VP (VBG controlling) (NP (NN B) (NN cell) (NN growth))))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (ADVP (RB now)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT a) (JJ null) (NN mutation)) (PP (IN in) (NP (NN btk))) (VP (VBN known) (S (VP (TO to) (VP (VB cause) (NP (DT the) (JJ xid) (NN phenotype))))))) (VP (VBZ prevents) (NP (NP (JJ BCR-induced) (NN activation)) (PP (IN of) (NP (NN NF-kappaB))))))))) (. .)))
(S1 (S (S (NP (DT This) (NN defect)) (VP (MD can) (VP (VB be) (VP (VBN rescued) (PP (IN by) (NP (NP (NN reconstitution)) (PP (IN with) (NP (JJ wild-type) (NN BTK))))))))) (. .)))
(S1 (S (S (NP (DT This) (NN mutation)) (ADVP (RB also)) (VP (VBZ interferes) (PP (IN with) (NP (NP (JJ BCR-directed) (NN activation)) (PP (IN of) (NP (NP (NP (NN IkappaB) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN IKK)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB normally)) (VP (VBZ targets) (NP (DT the) (NN NF-kappaB) (NN inhibitor) (NN IkappaBalpha)) (PP (IN for) (NP (NN degradation)))))))))))) (. .)))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN BTK)) (VP (VBZ couples) (NP (NP (NN IKK)) (CC and) (NP (NN NF-kappaB))) (PP (TO to) (NP (DT the) (NN BCR)))))))) (. .)))
(S1 (S (S (NP (NP (NN Interference)) (PP (IN with) (NP (DT this) (NN coupling) (NN mechanism)))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NN B) (NN cell) (NNS deficiencies)) (VP (VBN observed) (PP (IN in) (NP (NP (NN XLA)) (CC and) (NP (NN xid)))))))))) (. .)))
